Table 3.
Test set (n = 100) | ||
---|---|---|
Hazard ratio | P | |
APA score ≥5 | 3.0 | 0.03 |
T2, T3 | 2.6 | NS |
N1, N2 | 4.7 | 0.002 |
Age ≥70 years | 0.3 | 0.02 |
Male | 1.0 | NS |
Positive smoking history | 2.2 | NS |
Non-adenocarcinoma | 1.6 | NS |
Test set (n = 100) | ||
---|---|---|
Hazard ratio | P | |
Loss of PABPN1† | 3.5 | 0.01 |
Loss of CPEB1† | 2.1 | NS |
Gain of MKI67† | 1.7 | NS |
Gain of TOP2A† | 2.1 | NS |
Gain of MCM2† | 0.4 | NS |
Gain of E2F1† | 3.9 | 0.02 |
The median expression value of each gene was used as the threshold to divide the patients into two groups; those with either loss or gain of expression. APA, alternative polyadenylation; NS, not significant.